(BFW) Accor May Be Worth EU45/Shr by 2016, Exane Says, Raises PT

+------------------------------------------------------------------------------+

Accor May Be Worth EU45/Shr by 2016, Exane Says, Raises PT 2014-02-10 09:23:57.316 GMT

By Heather Burke Feb. 10 (Bloomberg) -- Accor’s new strategy to separate business into hotel owning and operating may boost accountability, capital allocation through changed mgmt incentives, Exane says. * In HotelInvest may need ~EU2b to buy back ~200 hotels from its good quality leased properties to hit target of >75% net oper. inc. from owned hotels * Could finance through cash, debt, possible raising equity * May lead to partial listing of HotelInvest * Accor may be worth EU45-shr in 2016 assuming co. ends 200 weak leases, buys back 200 good ones * PT raised to EU36 from EU31, rates neutral

For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO>

--Editor: Gaurav Panchal

To contact the reporter on this story: Heather Burke in London at +44-20-7673-2044 or hburke2@bloomberg.net

To contact the editor responsible for this story: James Ludden at +44-20-7673-2645 or jludden@bloomberg.net

FT : Dealmaking is back – up to a point

Whatever occurs will be pale echo of heyday

This column goes to press early, so it is written without knowledge of whether we are upon another “Merger Monday”. Deals are always most likely to be announced on Mondays as this allows executives, boards and lawyers to thrash out details over the weekend. But it seems a safe prediction that whatever deals this Monday brings, it will be a pale echo of the “Merger Mondays” that enlivened the corporate sector throughout the late 1990s.
Raw figures on deal volumes brook little argument. In January, mergers and acquisitions activity in the US was up impressively compared with the first month of 2012 – trebling from $46bn to $153bn, according to Thomson Reuters. This shows a return of animal spirits but it is tiny compared with January 2000, when deals worth $279bn were announced.

This is also not the peak January deal volume for the post-crisis era, as more money was transacted in the US in January 2011. After that, confidence dissipated as US politics grew uglier.
Globally, the picture is similar, although the rise in Asian dealmaking over the past decade compensates for weakness in Europe. According to S&P Capital IQ, global M&A for January clocked in at $355bn, more than double January 2013 ($155.6bn) but still short of the high watermark of 2000 ($431bn).
At one level, this could be good news. The first “Merger Monday” of 2000 brought news that AOL was buying TimeWarner for $153bn, in a disastrous deal that many consider the worst of all time. Heavy deal volume indicates that executives are growing overconfident and wasting their shareholders’ money, so it may be good that they are now more cautious. The volumes of the late 1990s were in many ways a symptom of a historic bubble. Nobody should want to see them repeated.
But at another level, it should be a cause for concern. Deal volume tends to be a function of the price of debt (still very cheap), and the cost of the acquirers’ equity. The higher the multiple at which a company is trading, the more likely it is to attempt mergers funded with stock – even if its target is also overpriced.
After 2013’s rise in the S&P 500, driven mostly by higher multiples, companies can do deals more cheaply than in many years. Why are they not doing so?
A positive answer may be that they have learnt the lesson of the 1990s and are not doing deals that will not boost their share price. Note that last year’s deals were generally greeted by the market as positive moves by the acquirers. According to Dealogic, acquirers’ stock rose, by an average of 4 per cent, on the days they announced takeovers. The figures are for deals of $1bn or more, and by far the most positive response to deals on record. From 1996 to 2011, acquirers’ stock on average fell on the day they announced deals every year. So executives are growing more sensible.
Another reason is that executives, like everyone else, remain unconvinced by the economic recovery and fear that asset prices have only been rising because of the intervention of the Federal Reserve. The choppy markets of January will not have made them any more confident.
They may also think that there are better ways to boost their return on equity than buying other companies. The latest Deloitte survey of chief financial officers of large UK companies found greater confidence and a desire to expand. But only 23 per cent named acquisitions as a priority. It lagged behind cost-cutting, improving cash flow, and introducing new products or expanding into new markets.
Why might CFOs put dealmaking so low on their list of priorities? We may be bumping up against the limits of M&A. In this environment, nationalism can thwart cross-border deals, as evidenced by various failed attempts to merge rival securities exchanges in the last few years, or by Canada’s decision to block BHP’s proposed $39bn acquisition of PotashCorp in 2010.
Companies also face more active competition authorities. Megamergers on the scale seen in banking during the 1990s are unlikely to return, on competition grounds, and also because regulators think that the financial system would be safer if banks grew smaller, not larger.
Several industrial sectors have also reshuffled themselves as far as the competition authorities will allow. Persistently high profit margins might well show that dealmaking has brought down capacity and reduced competition. To go any further would be to go too far.
Developments such as the high cost in airport slots that the US Department of Justice demanded before permitting the merger of AMR and US Airways last month indicate that big strategic mergers are harder to do than before.
Dealmaking is coming back. This is healthy, as it shows returning confidence. But it is hard to imagine that it will ever be at the levels seen in the 1990s, at least in the US and Europe. That is also healthy.

(Citi) L'Oreal : Will Multiple Contraction Consume EPS Accretion in a Buyback


Original Message From: LAURENT CHEKROUN () At: 2/10 09:31:35
Will Multiple Contraction Consume EPS Accretion in a Buyback Scenario?

* We remain Neutral on L'Oréal, even if it buys back the Nestlé stake (although we don’t think it will)
— Whilst there has been much debate about the potential mechanics of L’Oréal buying back Nestlé’s 29% stake, we think subsequent valuation multiples would be just as important. Although we expect Nestlé to maintain the status quo, if we are wrong we see gradual post deal P/E multiple contraction (down to ~20x), effectively offsetting the mechanical earnings accretion (of ~15-20%), which broadly supports the current share price, but does not provide any basis for significant upside.

* Questioning the supports of L'Oréal's rich multiple — We think L’Oréal has
commanded a premium trading multiple for i) the potentially longevity of growth for
HPC companies versus other staples categories (given lower levels of penetration
in Emerging Markets), ii) the perception that L’Oréal is a premium growth business
and iii) balance sheet optionality. Whilst we tend to agree with the first point, we
disagree with the second and think a transaction would consume the third.

* Good, but not exceptional growth — We think the days of L’Oréal sustainably
delivering 6-8% organic sales growth are gone. We expect the company to deliver
~5% growth on an ongoing basis, which is strong, but broadly in line with other
leading global staples companies.

* Normalising the balance sheet — We model net cash of ~€3.0bn (~0.6x EBITDA)
in 2013, rising to ~€4.5bn (~0.9x EBITDA) in 2014. On a pro-forma basis, assuming
a Sanofi plus debt funded buyback of the Nestlé stake, 2013/14 net debt/EBITDA
would increase to ~2.3x/1.9x, at the more geared end of the peer group.

* Results on 10 February — L’Oréal’s full year results after the close on Monday are
likely to provide further evidence of the relative resilience of HPC and L’Oréal’s
good execution within that group. We expect 5.0% organic growth for the quarter
and 4.9% for the year. Combined with 35bps of margin expansion, we expect full
year EPS of €5.05 vs. consensus of €5.09.

(BFW) *ITALY BANKS MAY HAVE UP TO EU15B CAPITAL GAP, SABATINI SAYS

+------------------------------------------------------------------------------+

BN 02/10 08:34 *ITALY BANKING ASSN GEN. MANAGER SABATINI COMMENTS IN INTERVIEW

+------------------------------------------------------------------------------+

*ITALY BANKS MAY HAVE UP TO EU15B CAPITAL GAP, SABATINI SAYS 2014-02-10 08:34:41.685 GMT

--DAN LIEFGREEN

-0- Feb/10/2014 08:34 GMT

(Citi) L'Oreal : Will Multiple Contraction Consume EPS Accretion in a Buyback

Will Multiple Contraction Consume EPS Accretion in a Buyback Scenario?

* We remain Neutral on L'Oréal, even if it buys back the Nestlé stake (although we don’t think it will)
— Whilst there has been much debate about the potential mechanics of L’Oréal buying back Nestlé’s 29% stake, we think subsequent valuation multiples would be just as important. Although we expect Nestlé to maintain the status quo, if we are wrong we see gradual post deal P/E multiple contraction (down to ~20x), effectively offsetting the mechanical earnings accretion (of ~15-20%), which broadly supports the current share price, but does not provide any basis for significant upside.

* Questioning the supports of L'Oréal's rich multiple — We think L’Oréal has
commanded a premium trading multiple for i) the potentially longevity of growth for
HPC companies versus other staples categories (given lower levels of penetration
in Emerging Markets), ii) the perception that L’Oréal is a premium growth business
and iii) balance sheet optionality. Whilst we tend to agree with the first point, we
disagree with the second and think a transaction would consume the third.

* Good, but not exceptional growth — We think the days of L’Oréal sustainably
delivering 6-8% organic sales growth are gone. We expect the company to deliver
~5% growth on an ongoing basis, which is strong, but broadly in line with other
leading global staples companies.

* Normalising the balance sheet — We model net cash of ~€3.0bn (~0.6x EBITDA)
in 2013, rising to ~€4.5bn (~0.9x EBITDA) in 2014. On a pro-forma basis, assuming
a Sanofi plus debt funded buyback of the Nestlé stake, 2013/14 net debt/EBITDA
would increase to ~2.3x/1.9x, at the more geared end of the peer group.

* Results on 10 February — L’Oréal’s full year results after the close on Monday are
likely to provide further evidence of the relative resilience of HPC and L’Oréal’s
good execution within that group. We expect 5.0% organic growth for the quarter
and 4.9% for the year. Combined with 35bps of margin expansion, we expect full
year EPS of €5.05 vs. consensus of €5.09.

(Citi) Akzo Nobel : Upgraded to Buy

Restructuring to drive value and share price; upgrade to Buy

* Restructuring — Akzo is a compelling restructuring story where efforts are similar
to the earlier course of actions but intentions are solid and the focus of management
has shifted from defined cost cutting to continuous improvement. This should not
only help to contain costs and improve margins but should also result in a more
efficient and agile organization, ready to bridge performance gap between Akzo and
its peers. Moreover, this new restructuring plan has taken its course at trough cycle
and despite weaker-than-expected volumes, severe FX volatility that hit sales
disproportionately to raw material costs; the gross profit margin rose 90bp in 2013.

* Re-Rate — Despite Akzo’s share price recent run-up, it has underperformed coating
index by more than 50% in the past two years. In part this reflects weak European
coating market vs. recovery in the US housing industry and part reflects weak
positioning of Akzo Decorative business. However, with its restructuring program
and potential European market recovery, Akzo is set to leverage the volume
improvement to margins. We expect 250bps EBITDA margin improvement by 2015
which should help closing the margin gap vs. its peers and hence re-rate.

* Estimate changes — We raise our 2014 EPS estimate by 8% and medium-term
earnings profile (2016 and beyond) by about 4-5%. This is driven by our view of the
group’s enhanced competitiveness through successful delivery of the restructuring
program. Accordingly, we raise our TP to €65 (from €48), set at about 5% discount
to DCF derived fair value of €70/shr and upgrade Akzo to Buy from Neutral.

* Buy Rating — While macro fundamentals are mixed (forex neg. but GDP trends
positive and raw material costs under control), restructuring is clearly improving
Akzo competitive position. The pension deficit looks under control and the net debt
position has improved although substantially due to asset sales. Trading conditions
seems bottomed out and we believe the long term earnings capacity of the business
is going to benefit from the measures to boost competitiveness, which is the key
focus of management action now. Buy.

(BFW) Tele2 Norway Exit Would Make Full Breakup More Probable: Nordea

+------------------------------------------------------------------------------+

Tele2 Norway Exit Would Make Full Breakup More Probable: Nordea 2014-02-10 08:04:55.453 GMT

By Sam Chambers Feb. 10 (Bloomberg) -- Tele2 may seek to acquire Norwegian spectrum, enter into a network JV or sell its Norwegian unit, Nordea says. * Says all options would create upside to co’s fair value and in the event of a full breakup, Tele2 may fetch SEK95 - SEK100/shr (~31% upside to Friday’s close) * Upgrades stock to buy; increases its PT by 9% after adding 33% of its breakup premium * Berenberg (buy) says with its poorly positioned Norwegian business and rising competitive threats in Dutch mobile, the time for a full breakup is now * Sees SEK12/shr upside should co. be broken up * NOTE: Tele2 erased losses to close 3.9% higher after FY results on Feb 7; TMT Finance reported Hutchison is advancing talks with Tele2 over purchase of its Swedish unit * NOTE: Tele2 said it’s a buyer in any Swedish M&A deal

For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO>

To contact the reporter on this story: Sam Chambers in London at +44-20-7673-2021 or schambers7@bloomberg.net

To contact the editor responsible for this story: James Ludden at +44-20-7673-2645 or jludden@bloomberg.net

(GS) Portfolio Strategy : cashback

From cash hoarding to distribution

* Cash hoarding since the ‘Great Recession’ to ease
During the ‘Great Recession’, companies hoarded cash. Cash-to-asset ratios
are high and leverage for non-financials is comparably low. With less macro
uncertainty and a falling equity risk premium, focus on corporate use of cash
increases. In addition, the cost of credit remains close to multi-year lows,
particularly relative to the cost of equity, pointing to re-leveraging.

* Investment spending losing out to cash returns
Over the last decade, European companies (ex financials) spent a smaller
proportion of their cash on investments for growth (capex and M&A) while
increasing returns to shareholders (in particular dividends). Capex is still
the largest cash expense and at a new peak, but growth has lagged that of
dividends and we do not expect a reversal of that trend. Less investment
spending does not have to indicate lack of growth. Declining capital
intensity due to outsourcing, low capital goods inflation, and new
technology led to a structural decline in capex relative to sales, in our view.

* Higher cash returns are positive for investors
We expect continued growth in cash returns and recommend several
strategies to benefit: (1) High dividend yield + growth-basket (Bloomberg:
GSSTHIDY) which aims to avoid ‘dividend yield traps’; (2) companies with
the potential for share buybacks; and (3) EURO STOXX 50 dividend swaps.

>>> Boeing forecasts $1.9 trln 20-year market for new airplanes in Asia Pacific

Boeing forecasts $1.9 trln 20-year market for new airplanes in Asia Pacific

Boeing says strong economic and passenger growth will be main drivers of new airplane demand in the Asia Pacific region. Boeing estimates the region's airlines will need an additional 12,820 airplanes valued at $1.9 trillion, representing 36 percent of the world's new airplane deliveries over the next 20 years.

Boeing's data projects that passenger airlines in the region will rely primarily on single-aisle airplanes such as the Next-Generation 737 and the 737 MAX, a new-engine variant of the market-leading 737, to connect passengers. Single-aisle airplanes will represent 69 percent

For long-haul traffic, Boeing forecasts twin-aisle airplanes such as the 747-8 Intercontinental, 777 and the 787 Dreamliner will account for 28 percent of new airplane deliveries. Boeing's recently launched 787-10 and 777X also will support the demand for fuel-efficient twin-aisle airplanes in the region.